Record

RefNoEC/1988/34
Previous numbersCert XXII, 131
LevelItem
TitleShooter, Eric Manvers: certificate of election to the Royal Society
Date1981
DescriptionCitation typed. Letter regarding nationality attached
CitationDistinguished for his studies of the chemistry and biochemistry of nerve growth factor (NGF). Showed that NGF consists of two peptide chains of identical sequence but unequal length, associated non covalently. Crystallised NGF and showed that activity is unaffected by removal of N terminal octapeptide or C-terminal arginine. In the cell is in the form of a 7S complex with a specific arginine endopeptidase and alpha-subunits which inhibit the peptidase and nerve growth activity; the 7S complex is secreted in the saliva. Demonstrated two classes of cellular receptor for NGF. The high affinity receptor is only present at the developmental age when the neurons are responsive. Discovered a haemoglobin variant with abnormal alpha and beta chains giving evidence of two synthetic genes.
Extent2 sheets
AccessStatusClosed
Fellows associated with this archive
CodePersonNameDates
NA6182Shooter; Eric Manvers (1924 - 2018)1924 - 2018
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView